MedTrace Logo

A Primary Care, EHR- Based Strategy to Promote Safe and Appropriate Drug Use

NCT01669473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 541

Last updated 2016-09-22

No results posted yet for this study

Summary

This study seeks to evaluate a low-literacy strategy in a primary health care setting for promoting safe and effective prescription medication use among English and Spanish-speaking patients with diabetes.

The investigators hypothesize that in comparison with patients receiving standard care, the patients that received the Electronic Health Record (EHR) strategy will 1) demonstrate better understanding of how to safely dose out their medication regimen; 2) have fewer discrepancies in their medication lists; 3) take their medication regimen more efficiently; 4) have greater adherence to their medication regimen.

Conditions

  • Diabetes Mellitus Type I
  • Diabetes Mellitus Type II

Interventions

OTHER

EHR Based Strategy to promote Safe and Appropriate Drug Use

The printed tools presented in the intervention include: 1. Medication Review: a consolidated list of the medications a patient is currently taking. 2. Medication Sheet: a medication information sheet, including simplified prescription instructions, for each medication that a patient is newly prescribed. 3. Medication List: a table that lists all medications taken by the patient and provides an orientation on how to best organize and simplify their medication regimen

Sponsors & Collaborators

Principal Investigators

  • Bruce Lambert, PhD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-08-31
Completion
2016-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01669473 on ClinicalTrials.gov